-
Entity
-
Individual
-
Location
-
C/O Acrivon Therapeutics, Inc., 480 Arsenal Way, Suite 100, Watertown, MA
-
Summary
-
The estimated net worth of Peter Blume-Jensen is at least $17.1M dollars as of November 25, 2024. Peter Blume-Jensen is the President and CEO, Director of Acrivon Therapeutics, Inc. and owns shares of Acrivon Therapeutics, Inc. (ACRV) stock worth about $17.1M.